Marta Hernandez-Conde

Madrid, MD, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 31 publications

Corrigendum to 'Progression to cirrhosis in chronic hepatitis D with mild-to-moderate fibrosis: Insights from a multicenter European cohort' [JHEP Reports (2026) 19;8(8):101898].

Corrigendum to 'Progression to cirrhosis in chronic hepatitis D with mild-to-moderate fibrosis: Insights from a multicenter European cohort' [JHEP Reports (2026) 19;8(8):101898].

Journal: JHEP reports : innovation in hepatology

Published: September 03, 2026

MASLD and Pancreatic Diseases: From Shared Mechanisms to Clinical Implications and Future Directions.

MASLD and Pancreatic Diseases: From Shared Mechanisms to Clinical Implications and Future Directions.

Journal: Nutrients

Published: June 23, 2026

Progression to cirrhosis in chronic hepatitis D with mild-to-moderate fibrosis: Insights from a multicenter European cohort.

Progression to cirrhosis in chronic hepatitis D with mild-to-moderate fibrosis: Insights from a multicenter European cohort.

Journal: JHEP reports : innovation in hepatology

Published: November 20, 2025

Progression to cirrhosis in chronic hepatitis D with mild-to-moderate fibrosis: Insights from a multicenter European cohort.

Progression to cirrhosis in chronic hepatitis D with mild-to-moderate fibrosis: Insights from a multicenter European cohort.

Journal: JHEP reports : innovation in hepatology

Published: November 20, 2025

Characterizing Hepatitis Delta in Spain and the gaps in its management.

Characterizing Hepatitis Delta in Spain and the gaps in its management.

Journal: Gastroenterologia y hepatologia

Published: May 28, 2024

Metabolic liver disease: A new preventable pandemic.

Metabolic liver disease: A new preventable pandemic.

Journal: Revista de gastroenterologia de Mexico (English)

Published: April 08, 2022

Editorial: clinical impact of sofosbuvir renal toxicity-more light on the way.

Editorial: clinical impact of sofosbuvir renal toxicity-more light on the way.

Journal: Alimentary pharmacology & therapeutics

Published: April 01, 2022

A nomogram as an indirect method to identify sarcopenia in patients with liver cirrhosis.

A nomogram as an indirect method to identify sarcopenia in patients with liver cirrhosis.

Journal: Annals of hepatology

Published: March 08, 2022

Prevalence estimation of significant fibrosis because of NASH in Spain combining transient elastography and histology.

Prevalence estimation of significant fibrosis because of NASH in Spain combining transient elastography and histology.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: January 12, 2022

Increased risk of MAFLD and Liver Fibrosis in Inflammatory Bowel Disease Independent of Classic Metabolic Risk Factors.

Increased risk of MAFLD and Liver Fibrosis in Inflammatory Bowel Disease Independent of Classic Metabolic Risk Factors.

Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

Published: October 27, 2021

Compound Endoscopic Morphological Features for Identifying Non-Pedunculated Lesions ≥20 mm with Intramucosal Neoplasia.

Compound Endoscopic Morphological Features for Identifying Non-Pedunculated Lesions ≥20 mm with Intramucosal Neoplasia.

Journal: Cancers

Published: September 18, 2021

Non-malignant portal vein thrombosis in a cohort of cirrhotic patients: Incidence and risk factors.

Non-malignant portal vein thrombosis in a cohort of cirrhotic patients: Incidence and risk factors.

Journal: Hepatology research : the official journal of the Japan Society of Hepatology

Published: May 10, 2021

Showing 1-12 of 31

Last Updated: 09/26/2026